People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ventus Therapeutics U.S., Inc. | — | Biotechnology | Series C | $186.8M | $1.6B | 2022 |
| Monte Rosa Therapeutics, Inc. | — | Biotechnology | Series C | $143.0M | $3.0B | 2020 |
| IMV Inc. | — | Biotechnology | Seed | $4.3M | $14.8M | 2021 |
Markus Warmuth at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Markus Warmuth on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Ali Behbahani | 1 | 17 |
| Jerel Davis | 1 | 13 |
| BRADLEY BOLZON | 1 | 10 |
| Josh Resnick | 1 | 7 |
| Michael Bailey | 1 | 6 |
| Hao Wu | 1 | 5 |
| Andrew Hall | 1 | 4 |
| Alexander Mayweg | 1 | 4 |
| John Cassidy | 1 | 3 |
| Shermaine Tilley | 1 | 3 |
| Jane Pritchett Henderson | 1 | 3 |
| Julia P. Gregory | 1 | 3 |
| Julia Gregory | 1 | 3 |
| Steven James | 1 | 3 |
| Kyle Kuvalanka | 1 | 3 |
| Kim Blackwell | 1 | 3 |
| Daniel Koerwer | 1 | 2 |
| Chandra P. Leo | 1 | 2 |
| Michael Kalos | 1 | 2 |
| Brendan Bulik-Sullivan | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.